In HCC, CTC exerts anti-VM effects by suppressing the expression of VEGFA and MMP9, inhibiting the EMT process through downregulation of N-cadherin and Vimentin, and upregulating the protein expression of E-cadherin (Gao et al., 2024). Here, MMP9 is linked to hepatocellular carcinoma.